• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种抑制诱变 SOS 应答的抑制剂的开发,该抑制剂可抑制喹诺酮类抗生素耐药性的演变。

Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance.

作者信息

Bradbury Jacob D, Hodgkinson Thomas, Thomas Adam M, Tanwar Omprakash, La Monica Gabriele, Rogga Vanessa V, Mackay Luke J, Taylor Emilia K, Gilbert Kiera, Zhu Yihua, Sefton Amber Y, Edwards Andrew M, Gray-Hammerton Charlotte J, Smith Gerald R, Roberts Paul M, Walsh Timothy R, Lanyon-Hogg Thomas

机构信息

Department of Pharmacology, University of Oxford OX1 3QT UK

Ineos Oxford Institute for Antimicrobial Research, Sir William Dunn School of Pathology, University of Oxford OX1 3RE UK.

出版信息

Chem Sci. 2024 May 16;15(25):9620-9629. doi: 10.1039/d4sc00995a. eCollection 2024 Jun 26.

DOI:10.1039/d4sc00995a
PMID:38939155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11206376/
Abstract

Antimicrobial resistance (AMR) is a growing threat to health globally, with the potential to render numerous medical procedures so dangerous as to be impractical. There is therefore an urgent need for new molecules that function through novel mechanisms of action to combat AMR. The bacterial DNA-repair and SOS-response pathways promote survival of pathogens in infection settings and also activate hypermutation and resistance mechanisms, making these pathways attractive targets for new therapeutics. Small molecules, such as IMP-1700, potentiate DNA damage and inhibit the SOS response in methicillin-resistant ; however, understanding of the structure-activity relationship (SAR) of this series is lacking. We report here the first comprehensive SAR study of the IMP-1700 scaffold, identifying key pharmacophoric groups and delivering the most potent analogue reported to date, OXF-077. Furthermore, we demonstrate that as a potent inhibitor of the mutagenic SOS response, OXF-077 suppresses the rate of ciprofloxacin resistance emergence in . This work supports SOS-response inhibitors as a novel means to combat AMR, and delivers OXF-077 as a tool molecule for future development.

摘要

抗菌耐药性(AMR)对全球健康构成了日益严重的威胁,有可能使众多医疗程序变得极其危险而无法实施。因此,迫切需要通过新的作用机制发挥作用的新分子来对抗AMR。细菌DNA修复和SOS反应途径促进病原体在感染环境中的存活,还会激活超突变和耐药机制,使这些途径成为新疗法的有吸引力的靶点。小分子,如IMP-1700,可增强DNA损伤并抑制耐甲氧西林菌中的SOS反应;然而,目前缺乏对该系列结构-活性关系(SAR)的了解。我们在此报告了对IMP-1700支架的首次全面SAR研究,确定了关键药效基团,并提供了迄今为止报道的最有效的类似物OXF-077。此外,我们证明,作为诱变SOS反应的有效抑制剂,OXF-077可抑制环丙沙星耐药性在……中的出现率。这项工作支持将SOS反应抑制剂作为对抗AMR的一种新手段,并将OXF-077作为未来开发的工具分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/3c289532a09a/d4sc00995a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/cfdddfc43b3b/d4sc00995a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/fb4b37e6e054/d4sc00995a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/74103f0f98c3/d4sc00995a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/3c289532a09a/d4sc00995a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/cfdddfc43b3b/d4sc00995a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/fb4b37e6e054/d4sc00995a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/74103f0f98c3/d4sc00995a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/11206376/3c289532a09a/d4sc00995a-f3.jpg

相似文献

1
Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance.一种抑制诱变 SOS 应答的抑制剂的开发,该抑制剂可抑制喹诺酮类抗生素耐药性的演变。
Chem Sci. 2024 May 16;15(25):9620-9629. doi: 10.1039/d4sc00995a. eCollection 2024 Jun 26.
2
Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus.鉴定出一种强效的小分子抑制剂,可增强耐甲氧西林金黄色葡萄球菌中喹诺酮类抗生素的活性。
Bioorg Med Chem. 2019 Oct 15;27(20):114962. doi: 10.1016/j.bmc.2019.06.025. Epub 2019 Jun 15.
3
Targeting the bacterial SOS response for new antimicrobial agents: drug targets, molecular mechanisms and inhibitors.针对细菌 SOS 反应的新型抗菌药物:药物靶点、分子机制和抑制剂。
Future Med Chem. 2021 Jan;13(2):143-155. doi: 10.4155/fmc-2020-0310. Epub 2021 Jan 7.
4
Quinolone Resistance Reversion by Targeting the SOS Response.喹诺酮类耐药性的 SOS 反应靶向逆转。
mBio. 2017 Oct 10;8(5):e00971-17. doi: 10.1128/mBio.00971-17.
5
Anti-mutagenic agent targeting LexA to combat antimicrobial resistance in mycobacteria.靶向 LexA 的抗诱变剂,以对抗分枝杆菌中的抗菌药物耐药性。
J Biol Chem. 2024 Sep;300(9):107650. doi: 10.1016/j.jbc.2024.107650. Epub 2024 Aug 8.
6
Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.抑制 SOS 反应可改变喹诺酮类耐药大肠杆菌的时空演变、抗生素后效应、细菌适应性和生物膜形成。
J Antimicrob Chemother. 2019 Jan 1;74(1):66-73. doi: 10.1093/jac/dky407.
7
The Landscape of Phenotypic and Transcriptional Responses to Ciprofloxacin in Acinetobacter baumannii: Acquired Resistance Alleles Modulate Drug-Induced SOS Response and Prophage Replication.铜绿假单胞菌对环丙沙星表型和转录反应的研究:获得性耐药等位基因调节药物诱导的 SOS 反应和噬菌体复制。
mBio. 2019 Jun 11;10(3):e01127-19. doi: 10.1128/mBio.01127-19.
8
Baicalein suppresses the SOS response system of Staphylococcus aureus induced by ciprofloxacin.黄芩素抑制环丙沙星诱导的金黄色葡萄球菌的SOS反应系统。
Cell Physiol Biochem. 2011;28(5):1045-50. doi: 10.1159/000335791. Epub 2011 Dec 15.
9
Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.基于结构的 3-(7-硝基-3-氧代-3,4-二氢喹喔啉-2-基)丙酰肼衍生物的设计与合成:作为新型细菌拓扑异构酶 II 抑制剂的体外、体内、计算和 SAR 研究。
Bioorg Chem. 2022 Dec;129:106186. doi: 10.1016/j.bioorg.2022.106186. Epub 2022 Oct 5.
10
Role of the SOS Response in the Generation of Antibiotic Resistance .SOS 响应在抗生素耐药性产生中的作用。
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0001321. doi: 10.1128/AAC.00013-21.

引用本文的文献

1
Bioenergetic stress potentiates antimicrobial resistance and persistence.生物能量应激会增强抗菌素耐药性和持续性。
Nat Commun. 2025 Jun 9;16(1):5111. doi: 10.1038/s41467-025-60302-6.
2
Development of a fluorescence-based assay for RecBCD activity using functional data analysis and design of experiments.利用功能数据分析和实验设计开发一种基于荧光的RecBCD活性检测方法。
RSC Chem Biol. 2025 Mar 17;6(5):772-779. doi: 10.1039/d4cb00291a. eCollection 2025 May 8.
3
Editorial: The Global Threats of Increasing Antimicrobial Resistance Require New Approaches to Drug Development, Including Molecular Antimicrobial Adjuvants.

本文引用的文献

1
A new antibiotic traps lipopolysaccharide in its intermembrane transporter.一种新型抗生素将脂多糖困在其跨膜转运蛋白中。
Nature. 2024 Jan;625(7995):572-577. doi: 10.1038/s41586-023-06799-7. Epub 2024 Jan 3.
2
RecBCD enzyme: mechanistic insights from mutants of a complex helicase-nuclease.RecBCD 酶:从复杂解旋酶-核酸酶的突变体中获得的机制见解。
Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0004123. doi: 10.1128/mmbr.00041-23. Epub 2023 Dec 4.
3
Porin-independent accumulation in Pseudomonas enables antibiotic discovery.在假单胞菌中,孔蛋白非依赖性积累使抗生素的发现成为可能。
社论:不断增加的抗菌药物耐药性对全球构成威胁,这需要新的药物研发方法,包括分子抗菌佐剂。
Med Sci Monit. 2024 Jul 1;30:e945583. doi: 10.12659/MSM.945583.
Nature. 2023 Dec;624(7990):145-153. doi: 10.1038/s41586-023-06760-8. Epub 2023 Nov 22.
4
Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.全球抗菌药物耐药性驱动因素:在人与动物接触界面的生态国家级研究。
Lancet Planet Health. 2023 Apr;7(4):e291-e303. doi: 10.1016/S2542-5196(23)00026-8.
5
Defects in DNA double-strand break repair resensitize antibiotic-resistant Escherichia coli to multiple bactericidal antibiotics.DNA 双链断裂修复缺陷使耐抗生素的大肠杆菌对多种杀菌抗生素重新敏感。
Microbiologyopen. 2022 Oct;11(5):e1316. doi: 10.1002/mbo3.1316.
6
Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.基于吡啶哌嗪的 RND 型多药外排泵变构抑制剂。
Nat Commun. 2022 Jan 10;13(1):115. doi: 10.1038/s41467-021-27726-2.
7
Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors.模拟β-内酰胺结合可实现广谱金属β-内酰胺酶抑制剂。
Nat Chem. 2022 Jan;14(1):15-24. doi: 10.1038/s41557-021-00831-x. Epub 2021 Dec 13.
8
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis.含尿素和硫脲化合物的最新进展:聚焦于药物化学和有机合成中的创新方法。
RSC Med Chem. 2021 May 13;12(7):1046-1064. doi: 10.1039/d1md00058f. eCollection 2021 Jul 21.
9
RexAB Promotes the Survival of Staphylococcus aureus Exposed to Multiple Classes of Antibiotics.雷克斯 AB 促进多种抗生素暴露的金黄色葡萄球菌的存活。
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0059421. doi: 10.1128/AAC.00594-21. Epub 2021 Jul 26.
10
Targeting the bacterial SOS response for new antimicrobial agents: drug targets, molecular mechanisms and inhibitors.针对细菌 SOS 反应的新型抗菌药物:药物靶点、分子机制和抑制剂。
Future Med Chem. 2021 Jan;13(2):143-155. doi: 10.4155/fmc-2020-0310. Epub 2021 Jan 7.